Read: 1065
The first international conference focused on lung cancer in China will convene researchers at the Beijing meeting from October 27-30. Collaborating between the University of California San Francisco UCSF, the University of Colorado Health Sciences Center, and the Chinese Academy of Medical Sciences, this event is med to educate both the medical community worldwide and within China on cutting-edge lung cancer therapies.
Leading researchers from UCSF will showcase their work surrounding targeted treatments, genomics, and other pioneering scientific advancements at this conference. The m is to provide insights into the most sophisticated approaches for patients battling lung cancer in light of the severe crisis it poses in China.
Lung cancer is experiencing an alarming prevalence in China, predicted by the World Health Organization's recent publication The Tobacco Atlas to escalate even further. With estimates that two million Chinese men will die annually from smoking by 2025 and considering only sixty percent of adults are aware that cigarettes cause lung cancer, significant barriers in healthcare exist.
We int to discuss the most advanced techniques avlable worldwide for treating lung cancer, stated David Jablons, MD, an associate professor of surgery at UCSF and program leader of the UCSF Thoracic Oncology Program. The enormity of the problem along with China's medical challenges are stark, yet we hope this conference will inspire the global scientific community to tackle the crisis.
Jablons conducts translational research into targeted cancer therapies as director of the UCSF Thoracic Oncology Laboratory. Although advancements in treatment are essential, he emphasized that prevention remns paramount.
Lung cancer screening through X-ray usually identifies cancers beyond their early treatable stages, Jablons sd. While a national trial using spiral computerized tomography CT scanning begins this year at 30 sites including UCSF, demonstrating the effectiveness of this method will take many years.
New diagnostic markers and technologies for the early detection of lung cancer are vital to improve patient prognosis according to UCSF researcher Liang You, MD, PhD. In Beijing, he will present his research into genetic markers that could facilitate early detection.
Furthermore, Jablons alongside co-author Biao He, PhD, highlighted recent findings on the Wnt signaling pathway, suggesting it plays an important role in lung cancer and may hold potential for cancer treatment by modulating this signaling pathway.
Notably, Chinese officials atting the conference include Shu-Jun Cheng, MD, chief executive scientist of the Chinese National Key Basic Research Program in Cancer. This program parallels the National Cancer Institute NCI in the U.S.
The UCSF Thoracic Oncology program provides comprehensive care for patients with various thoracic surgical conditions as well as an active research lab dedicated to exploring molecular carcinogenesis and developing gene therapies for lung cancer, mesothelioma, esophageal cancers, among others. The primary objective of this lab's scientists is translational research, ming to bridge laboratory discoveries to clinical application.
The collaboration between UCSF and global partners marks a pivotal step in addressing the growing lung cancer epidemic in China, highlighting both the urgency of medical advancements and international cooperation in healthcare solutions.
To subscribe to the latest updates from UC San Francisco News or become an advocate for health initiatives through volunteering opportunities at UCSF Medical Center, fundrsing, or by accessing career information and other resources listed on the site. that this is a 2024 version of a hypothetical annual conference, ensuring accurate and timely information.
: The detls provided are subject to change based on actual events or real-time data.
This article is reproduced from: https://www.ucsf.edu/news/2002/10/97296/beijing-conference-address-lung-cancer-crisis-china
Please indicate when reprinting from: https://www.81le.com/Tumor_Cancer/China_Lung_Cancer_Conference_2024.html
International Lung Cancer Conference in China Cutting Edge Therapies for Chinese Patients UCSF Collaborates on Global Health Crisis Lung Cancer Research and Prevention Strategies Advanced Medical Solutions from UCSF Epidemic Growth of Lung Cancer in China